I was doing so well on Ibrance and Faslodex, I thought I would be one of the lucky ones who stayed on it for five years without progression. After just two years, I developed a new bone met, and a small lesion in the hilem (?). My oncologist took me off Ibrance, then off Faslodex. The alternatives were chemo; Verzenio and something else; or a clinical trial. Since she felt the new lesions were small and slow growing, it was worth trying the clinical trial, since it would easier to take. It is a phase 1-2 trial of an oral medication that works like Faslodex, same mechanism.
I am skeptical about this, since 500mg of Faslodex stopped working, why would the oral version work? I have read that the oral version is absorbed better. I am sorry to be off Ibrance, since the combo was so effective.
Attended the conference on MBC. I am suddenly realizing I am not going to have an exceptionally good response, and the life expectancy numbers on average are not good. I generally, not always but often, feel well and have energy. Hard to believe I am dying. Well, not yet, but hard to believe sometimes that have a terminal illness.
So: does anything know about or had experience with this new oral fulvestrant? I know there are others that have been through Phase 3. This is a newer one. There is another arm that has the fulvestrant pill plus Ibrance. I am in the fulvestrant pill only branch, I guess because the oncologist thinks Ibrance failed. Is there any reason to hope this will work?